Healthcare Policies and Systems in Europe and China, a product of an interdisciplinary European Union-funded project, comprehensively investigates opportunities for mutual integration in the healthcare sector of the two regions and analyses policies at both national and local levels, the legal environment, medical practices, as well as the state of respective healthcare industries and related businesses. The book sheds light on both the potential benefits and obstacles to the integration of Chinese and Western medicine, as well as practices and industries in Europe and China. An interdisciplinary approach is adopted throughout using tools and technical knowledge derived from the economics, social sciences, legal and medical fields.This edited volume seeks to provide guidelines and policy proposals for policy-makers both in Europe and China, as well as offer operational suggestions for companies working in or with China, to enhance bilateral trade and investment flows. It also presents medical evidence and economic/legal analysis that will help boost the integration of traditional Chinese medicine with Western medicine through research studies. This is a recommended read for graduates, researchers and policy-makers seeking for a holistic understanding of healthcare policies and systems, both in theory and in practice.

This book explores the ongoing transition of China’s economy by examining how its healthcare industry is growing and changing. The coronavirus pandemic has reinforced one of the authors' key points: in our complex, fragile, and interconnected societies, the production of health is a vital strategic ‘industry’. The case of China is particularly salient, because of its economic and geopolitical significance, and the scale of the healthcare challenge it has faced. Adopting a multi-level perspective, the authors examine the entrepreneurial role of the Chinese government as it seeks to strengthen the competitiveness of domestic firms. They analyze the strategies employed to improve China’s technology and capacity for innovation, and discuss China’s strategies and policies to ensure knowledge acquisition and creation in the long-term, with particular reference to international scientific collaborations. This book is a must-read for students, researchers, and policymakers interested in the prospects and challenges posed by the growth of the Chinese healthcare industry and its global impact.

The People's Republic of China is one of the largest importers and exporters of food products in the world. After the melamine crisis fundamentally challenged its food legal infrastructure, the PRC now boasts one of the most modern systems of food law in the world. This makes Chinese food law very interesting for its own sake but also as a source for comparison and inspiration. This book aims to make Chinese food law accessible to a non-Chinese audience. The book follows the same legal-systematic approach that has proven its usefulness in explaining EU food law in the EU Food Law Handbook. Topics discussed include the history of Chinese food law, general principles, the institutional framework, the difference between food and edible agricultural products, the homology of food and medicine, authorization requirements for food additives, novel food materials, health foods, food for special medical purposes and infant formula, genetically modified organisms, maximum limits for residues and other contaminants, process requirements to prevent and deal with food safety incidents, labelling requirements including nutrition and health claims and food law enforcement. Where appropriate we have taken into account the perspective of businesses wishing to export to China. You don't need a background related to food, to law or to China to enjoy this book. Readers may include students or researchers with an interest in Chinese or comparative food law, but also public authorities, NGOs or food businesses who wish to better understand or to take inspiration from food law in the People's Republic of China.

Exploring the capacity and impact of decentralization within European health care systems, this book examines both the theoretical underpinnings as well as practical experience with decentralization.

This report provides a comprehensive assessment of the economic consequences of outdoor air pollution in the coming decades, focusing on the impacts on mortality, morbidity, and changes in crop yields as caused by high concentrations of pollutants.

"Today Singapore ranks sixth in the world in healthcare outcomes well ahead of many developed countries, including the United States. The results are all the more significant as Singapore spends less on healthcare than any other high-income country, both as measured by fraction of the Gross Domestic Product spent on health and by costs per person. Singapore achieves these results at less than one-fourth the cost of healthcare in the United States and about half that of Western European countries. Government leaders, presidents and prime ministers, finance ministers and ministers of health, policymakers in congress and parliament, public health officials responsible for healthcare systems planning, finance and operations, as well as those working on healthcare issues in universities and think-tanks should know how this system works to achieve affordable excellence."--Publisher's website.